Close
American Drug Delivery & Formulation Summit
Xylem

Press Releases

Monon Bioventures receives nearly $400,000 to develop Purdue-discovered glioblastoma treatment

Monon Bioventures LLCย has received a one-year, $398,314 Phase I Small Business Innovation Research, or SBIR, grant from the National Cancer Institute to demonstrate the feasibility of manufacturing a glioblastoma therapeutic created at theย Purdue University College of Pharmacy. โ€œGlioblastoma is one...

Debut Event Showcases Newest Trends in Drug Manufacturing and Delivery

Connect in Pharma โ€” the new annual event from Easyfairs โ€” had its debut launch on 14 & 15 September in Geneva. Key players from companies in the pharmaceutical industry, including Bayer, Merck, Pfizer, Roche, Johnson & Johnson and...

Abzena strengthens R&D capabilities to support rapid antibody discovery

Abzena, a leading CDMO providing integrated discovery, development and manufacturing of biologics and antibody drug conjugates (ADCs), has announced a significant upgrade to its research and development capabilities in Cambridge. This includes an investment in B cell discovery technologies...

Bora Pharmaceuticals partners with TaiRx, Inc. to manufacture breakthrough anticancer drug

Bora Pharmaceutical Laboratories Inc. (Zhunan), a division of Bora Pharmaceuticals has partnered with TaiRx, Inc., a premier Taiwan new drug development company, to manufacture a novel anticancer drug, CVM-1118. CVM-1118 is a new small molecule chemical entity being developed by...

Peli BioThermal Opens New Service Center In Japan

Peli BioThermal, the life science industryโ€™s partner from discovery to distribution, announces the opening of its new service center in Japan. The new facility, which is the latest location to be added to the companyโ€™s growing network in Asia,...

MedPharm collaborates with Mosanna to develop new drug to tackle Metabolic Obstructive Sleep Apnea

MedPharm, a global provider of contract topical and transdermal formulation development and manufacturing services, is pleased to announce that it will support Swiss Biotech company, Mosanna Therapeutics, in the development of a nasal spray (MOS-118) aimed at treating Metabolic...

Benchtop FT-NMR Applied to SARS-CoV-2 and ‘Long COVID’ Research Lowers the Barrier to Clinical Translation

Researchers at the Australian National Phenome Centre (ANPC) at Murdoch University have successfully detected and quantified newly discovered biomarkers of SARS-CoV-2 acute infections and of โ€˜Long COVIDโ€™. They used a benchtop Fourier Transform-nuclear magnetic resonance (FT-NMR) spectrometer with a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป